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Abstract: 
Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) is an innate 
immune receptor.  To investigate the role of Nod2 in susceptibility to the 
autoimmune disease, type 1 diabetes mellitus (T1DM), we generated Nod2
-/-
 
non-obese diabetic (NOD) mice.  The Nod2
-/-
NOD mice had different composition 
of the gut microbiota compared to Nod2
+/+
NOD mice and were significantly protected 
from diabetes, but only when housed separately from Nod2
+/+
NOD mice.  This 
suggested that T1DM susceptibility in Nod2
-/-
NOD mice is dependent on the 
alteration of gut microbiota, which modulated the frequency and function of 
IgA-secreting B-cells and IL-10 promoting T-regulatory cells.  Finally, colonizing 
germ-free NOD mice with Nod2
-/-
NOD gut microbiota significantly reduced 
pro-inflammatory cytokine-secreting immune cells but increased T-regulatory cells.  
Thus, gut microbiota modulate the immune system and T1D susceptibility.  
Importantly, our study raises a critical question about the housing mode in the 
interpretation of the disease phenotype of genetically-modified mouse strains in 
T1DM studies. 
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1. Introduction: 
Type 1 diabetes mellitus (T1DM) development is influenced by both 
genetic and environmental factors [1].  The incidence of T1DM has significantly increased 
worldwide [2-7] and environmental factors are thought to play a critical role in this.  Innate 
immunity protects hosts from bacterial invasion by recognizing bacterial components 
through their pattern recognition receptors (PRRs). These PRRs include Toll-like receptors 
(TLRs) and nucleotide-binding oligomerization domain-like receptors (NOD-like receptors, 
NLRs).  Interestingly, TLR deficiencies on the Non-Obese Diabetic (NOD) mouse 
background both increase susceptibility to and protect from T1DM [8-13].  Deficiency in 
MyD88, an adaptor protein that mediates most TLR signaling, induced complete protection 
from T1DM, which was abolished when MyD88
-/-
NOD mice were housed in germ-free (GF) 
conditions [14].  Therefore, interactions between the TLR family and gut microbiota 
regulate T1DM development.  However, much less is known about the role of NLR family 
members in T1DM susceptibility, in humans and mice.  We recently reported that NLRP3, 
an important inflammasome component, influences T1DM development by regulating 
chemokines and their receptors in both immune cells and islet beta cells, preventing immune 
cell migration to the targeted tissue [15].   
Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) is a cytosolic 
bacterial sensor of muramyl dipeptide that induces antimicrobial peptide release and 
inflammatory signaling required for maintenance of the homeostasis of gut microbiota 
[16-18].  Nod2 mutations are associated with high susceptibility to Crohn’s disease, a 
common inflammatory disorder of the bowel [19, 20].  Furthermore, Nod2 deficiency in 
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mice correlates with increased bacterial susceptibility [16, 21].  To investigate the role of 
Nod2 in a T1DM model, we generated NOD mice deficient in Nod2 (Nod2
-/-
NOD).  We 
hypothesized that Nod2 modulates T1DM development by regulating the composition of gut 
microbiota, which alters the immune cell function.  Our results fully supported our 
hypothesis and raise an important point about alteration of immunological phenotype by 
housing conditions.    
 
2. Materials and methods 
2.1. Mice 
NOD/Caj mice have been maintained at Yale University for approximately 30 years.  
Nod2
-/-
B6 mice [16] were obtained from the Jackson Laboratory.  They were backcrossed 
to NOD mice for 10 generations and the purity of the NOD genetic background was further 
confirmed by mouse genome scan (DartMouse).  The mice were housed in specific 
pathogen-free (SPF) or germ-free (GF) conditions in a 12-hour dark/light cycle.  All mice 
received irradiated food ad libitum and were housed in individually-ventilated filter cages 
(SPF) or open-topped cages within a gnotobiotic isolator (GF).  Three types of 
experimental breeding and four types of experimental housing strategies were applied in this 
study as summarized in Supplementary Table 1.  In the cohoused group (CH) equal 
numbers (2+2 or 3+3) of Nod2
+/+
NOD and Nod2
-/-
NOD mice were housed in the same cage, 
whereas non-cohoused (NCH) mice refers to Nod2
+/+
NOD and Nod2
-/-
NOD mice housed by 
genotype, i.e., Nod2
+/+
NOD mice were only housed together with Nod2
+/+
NOD and vice 
versa.  The use of mice in this study was approved by the Institutional Animal Care and 
Use Committee at Yale University. 
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2.2. Natural history of diabetes development 
Female Nod2
-/-
NOD and Nod2
+/+
NOD mice were assessed weekly for glycosuria for 
30 weeks.  Diabetes was confirmed by blood glucose of ≥250 mg/dL (≥13.9 mmol/L). 
 
2.3. Short term and long term co-housing 
Three to 4-week-old female Nod2
-/-
NOD or Nod2
+/+
NOD littermates were divided into 
groups, whereby Nod2
+/+
NOD and Nod2
-/-
NOD mice were housed in separate groups or 
co-housed in cages where the genotypes were mixed.  Experiments were terminated when 
the mice were aged 9-10 weeks or 30 weeks old. 
 
2.4. Histopathology and insulitis 
Pancreata from 12-week old female mice were fixed in 10% buffered formalin 
and embedded in paraffin.  Tissues were sectioned and stained with hematoxylin and 
eosin.  Insulitis was scored under light microscopy with the following grading scale: 
0, no insulitis; I, infiltration ＜25% of the islet; II, 25-75% infiltration; III, >75% 
infiltration.  A range of 170–212 islets were scored for insulitis in each group (n = 7–
8 mice).  Significance was determined using a Chi square test.  ** p<0.01. 
 
2.5. Extraction of gut bacterial DNA 
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Fecal samples from female Nod2
-/-
NOD and Nod2
+/+
NOD mice were collected from 
12-week old mice and resuspended in 300µl TE buffer containing 0.5% SDS and 200µg/ml 
Proteinase K.  Bacterial DNA was extracted as previously described [22].   
 
2.6. 16S rRNA sequencing and microbiota classification 
    The V4 region of the 16S rRNA gene was amplified from each DNA sample using a 
bar-coded broadly-conserved bacterial forward (5’-GTGCCAGCMGCCGCGGTAA-3’) and 
reverse primer (5’-GGACTACHVGGGTWTCTAAT-3’).  The PCR products were 
purified using a Qiagen gel extraction kit.  The DNA concentration was quantified and 
equimolar amounts of each sample were pooled and used for pyrosequencing with the Ion 
Torrent PGM sequencing system (Life Technologies).  The sequencing data were analyzed 
with the QIIME software package and UPARSE pipeline to pick operational taxonomic 
units (OTUs).  Taxonomy assignment was performed using representative sequences of 
each OTU.  Beta-diversity was calculated to compare differences between microbial 
communities, shown as Principal Coordinate Analysis (PCoA). 
 
2.7. Quantitative real-time PCR (qPCR) 
Quantitative real-time PCR (qPCR) was performed using Bio-Rad iQ5 qPCR detection 
system according to the manufacturer’s instructions.  The relative mRNA level of 
segmented filamentous bacteria (SFB) was determined using the 2-ΔΔCt method and 
normalization using the 16S rRNA values with SFB specific primers (forward primer: 
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5’-AGGAGGAGTCTGCGGCACATTAGC-3’ and reverse primer: 
5’-TCCCCACTGCTGCCTCCCGTAG-3’).  
 
2.8. Gut lumen IgA detection  
Gut contents were collected from Nod2
+/+
NOD and Nod2
-/-
NOD mice at 12 weeks of 
age by flushing the small intestine with 10 mls of sterile PBS.  The gut flush was then 
centrifuged (2000 rpm, 5mins, RT) and the supernatant was collected for IgA detection 
using ELISA (Southern Biotech) following the protocol described by Harriman et al [23].  
 
2.9. Interaction of gut bacteria and immune cells in co-culture with splenocytes. 
The large intestine was harvested from 2-month old female Nod2
-/-
NOD and 
Nod2
+/+
NOD mice and flushed with 5 mls of sterile PBS.  The gut contents were vortexed 
for 2 mins followed by centrifuging for 5 mins at low speed (52xg) to remove dietary 
residue.  The supernatant was transferred to a new tube and spun.  After washing the 
pellet twice more, the combined supernatant was centrifuged at 469xg to remove 
mammalian cells.  Bacteria in the supernatant were pelleted by centrifugation at high speed 
(1876xg, 5mins) and resuspended in PBS.  Bacterial concentration was measured with a 
spectrophotometer (Bio-Rad) and heat-inactivated at 90℃ for 20 mins. 10
8
 heat-inactivated 
bacteria were co-cultured with splenocytes (2x10
6
/ml) from Nod2
-/-
NOD or Nod2
+/+
NOD 
mice for 14 hours prior to ICC.  
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2.10. Oral Gavage 
Fresh fecal pellets were harvested from 4-5 week old Nod2
+/+
NOD or Nod2
-/-
NOD mice 
housed separately.  Pellets were homogenized and gently centrifuged to remove large 
particles (1xg, 10 minutes).  OD values were used to determine bacterial colony forming 
units (CFU).  Germ-free WT NOD mice were then colonized with 2x10
8
 CFU by oral 
gavage, and terminated for experiments 2-3 weeks after gavage.  Successful colonization 
was evaluated by 16S rRNA bacterial sequencing of fecal pellets from the ex-GF mice. 
 
2.11. Antibodies and reagents 
Briefly, cells were incubated with an Fc-blocking antibody (clone 2.4G2) at 4°C for 
15mins, prior to surface staining.  Antibodies to IgA (eBioscience; clone mA-6E1), IgG1 
(BioLegend; clone RMG1-1), IgG2b (BioLegend; clone RMG2b-1), CD4 (BioLegend; 
clone GK1.5), CD8α (BioLegend; clone 53-6.7), CD19 (BioLegend; clone 6D5), B220 
(BioLegend; clone RA3-6B2), TCRβ (BioLegend; clone H57-597), CD25 (BioLegend; 
clone 3C5) were used with viability determined using a Zombie Aqua
TM
 Fixable Viability 
Kit (Biolegend).  Treg cell staining was conducted using Tonbo Biosciences buffers 
(Foxp3/Transcription Factor Staining Buffer Kit; cat no: TNB-0607-KIT).  Cells were 
stained as above, then fixed for 1 hour at RT prior to permeabilzation.  The cells were then 
incubated with the 2.4G2 Fc-blocking antibody at 4°C for 15mins prior to staining with 
anti-FoxP3 PE (eBioscience; clone NRRF-30) for 30mins at 4°C.  Hybridoma supernatants 
containing mAbs used for cell purification or stimulation, were generously provided by the 
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late Charles Janeway Jr. (Yale University).  RPMI-1640 media and heat-inactivated FCS 
were purchased from Invitrogen and Gemini, respectively.  
 
2.12. Cell surface and Intracellular cytokine (ICC) staining 
Cells were stimulated with PMA (50ng/ml, Sigma) and ionomycin (500ng/ml, Sigma) 
in the presence of 1µl GolgiPlug
TM
 (BD) at 5x10
6
/ml in cell culture medium for 4.5 hours.  
Fc receptors were blocked using the Fc-blocking antibody (incubated at 4°C for 15mins), 
then the cells were stained (30mins at 4°C) with surface markers and viability dye.  The 
cells were then washed prior to fixation (20mins at RT) and permeabilization, using 
eBioscience
TM
 Intracellular fixation and permeabilization buffer set.  The cells were then 
washed, blocked with the Fc-blocking antibody and then stained with anti-IFNγ 
(BioLegend; clone XMG1.2), anti-IL17a (BioLegend; clone TC11-18H10.1) and anti-TNFα 
(BioLegend; clone MP6-XT22) for 30mins at 4°C.  
 
2.13. Treg suppression assays 
Splenic and pancreatic lymph node (PLN)-derived Treg cells were isolated using Treg 
magnetic isolation kits (Stem cell technology, positive selection of CD4
+
CD25
+
 T-cells) and 
mitomycin-c-treated. Total NOD splenic APCs (post T-cell depletion and 
mitomycin-c-treatment) were used as alloantigen-stimulators.  Purified splenic T cells from 
C57BL/6 mice were used as responders.  Treg function was examined by suppression of 
the mixed lymphocyte reaction (MLR).  Culture supernatants (to test secreted cytokines) 
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were collected on day 4 prior to 
3
H-thymidine addition for the last 18 hours of the 5-day 
culture to assess proliferation. 
 
2.14. Statistical analysis 
Statistical analysis was performed using GraphPad Prism 7 software.  Diabetes 
incidence was compared using log-rank test.  In vitro assays were analyzed with Student’s 
t test or ANOVA and P<0.05 was considered significant.  
 
3. Results：  
3.1. T1DM incidence in Nod2-deficient NOD mice was dependent on housing status  
We set up three independent observation groups (summarized in Supplemental Table 
1).  Firstly, we investigated spontaneous diabetes in Nod2
-/-
NOD mice and their co-housed 
(CH) Nod2
+/+
NOD littermates (all females) over 30 weeks, from Nod2
+/- 
breeding.  We 
found that Nod2
-/-
NOD mice developed diabetes similar to their WT littermates (Fig 1A).  
Secondly, to address the role of the gut microbiota (as Nod2 recognizes the bacterial 
component muramyl dipeptide) we set up another cohort of mice, in which Nod2
-/-
NOD and 
their Nod2
+/+
NOD female littermates from Nod2
+/- 
breeding were separately housed (i.e. 
multiple mice of the same genotype were housed together) after weaning (non-cohoused, 
NCH).  Interestingly, non-cohoused Nod2
-/-
NOD mice showed significantly reduced 
T1DM development (31% vs. 71%, p=0.003, Fig. 1B).  To confirm that the different 
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diabetes phenotype was due to the housing conditions, in a third set of experiments, the 
offspring from homozygous Nod2
-/-
NOD breeding and homozygous Nod2
+/+
NOD breeding 
were then co-housed after weaning at 3-4 weeks until 30 weeks old. Nod2
-/-
NOD and 
Nod2
+/+
NOD mice were housed separately as controls.  Similar to the results shown in Fig. 
1B, the non-cohoused Nod2
-/-
NOD mice had significantly reduced T1DM incidence 
compared to non-cohoused Nod2
+/+
NOD mice (33.3% vs. 86.7%, p=0.002, Fig. 1C).  
However, when the Nod2
-/-
NOD and Nod2
+/+
NOD mice were cohoused, the incidence of 
TIDM was increased in Nod2
-/-
NOD mice and indistinguishable from the Nod2
+/+
NOD 
counterparts, which had reduced incidence of diabetes (Fig. 1C).  To assess disease 
severity, we also investigated the islet infiltration in 12-week old prediabetic mice and found 
that Nod2
-/-
NOD mice had exacerbated islet infiltration when cohoused with WT 
Nod2
+/+
NOD mice (Fig. 1D).  These results suggested that the gut microbiota affected 
T1DM development.   
 
3.2. Diabetes susceptibility is modulated by altered gut microbiota in Nod2-deficient 
NOD mice  
We conducted further studies using non-littermate mice (from Nod2
-/-
NOD breeding 
or Nod2
+/+
NOD breeding) that were housed together (cohoused) or separately 
(non-cohoused) at weaning.  We specifically did not use Nod2
-/-
 and Nod2
+/+
 littermates in 
order to study how distinct microbiota, shaped by Nod2, influence the immune responses. 
To verify whether gut microbiota were responsible for modifying T1DM susceptibility, we 
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collected fresh fecal samples from pre-diabetic female Nod2
-/-
NOD and Nod2
+/+
NOD mice 
and conducted 16S rRNA sequencing.  Principal component analysis (PCA) revealed that 
the composition of gut microbiota from Nod2
-/-
NOD mice was very different from 
Nod2
+/+
NOD mice when they were not cohoused (Fig. 2A); however, this difference was 
eliminated upon cohousing the mice (Fig. 2B).  We further evaluated changes of the 
microbiota composition at 3 weeks (before housing changes) and at 8-9 weeks of age 
(non-cohoused and cohoused). Interestingly, the gut microbiota composition was 
dramatically altered in Nod2
-/-
NOD mice when cohoused compared to non-cohoused 
Nod2
-/-
NOD mice, with the latter similar to the microbiota composition they had at 3 weeks 
whereas the former were indistinguishable from the microbiota composition of 
Nod2
+/+
NOD mice  (Supplemental Fig. 1A).  Interestingly, Nod2
+/+
NOD mice also had a 
change in their microbiota when they were cohoused or non-cohoused, although the change 
was much more subtle.  This, however, suggests that the subtle changes in the microbiota 
of Nod2-sufficient mice over time may protect the mice from developing diabetes (Fig. 1C).   
We identified that Candidatus Arthromitus and Ruminococcus, which are of the 
phylum Firmicutes, and Adlercreutzia, of the phylum Actinobacteria, were significantly 
increased in cohoused Nod2
-/-
NOD mice compared with non-cohoused Nod2
-/-
NOD mice 
(Fig. 2C, D, G).  However, in the co-housed Nod2
+/+
NOD mice there was a significantly 
decreased frequency of Candidatus Arthromitus compared to non-cohoused Nod2
+/+
NOD 
mice (Fig. 2C).  A similar trend was also noted in other genera including Coprobacillus 
(Fig. 2F).  Interestingly, the effect of housing the mice had a stronger impact on the 
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microbiota compared with the Nod2 gene effect, where only Oscillospira showed a trend 
towards a gene effect, being increased in Nod2
-/-
NOD mice (Fig. 2E).   
 To test if SFB contribute to the disease protection in Nod2
-/-
NOD, we examined the 
abundance of SFB by qPCR in the fecal samples of Nod2-deficient or Nod2-sufficient NOD 
mice both co-housed and housed separately.  While there were no significant differences 
between non-cohoused and cohoused mice of the same Nod2 genotype, there was a 
significant difference between non-cohoused Nod2
+/+
NOD and Nod2
-/-
NOD mice (Fig. 2H, 
p＜0.05), with higher levels of SFB in non-cohoused Nod2
+/+
NOD mice.  Together, our 
data suggest that the diabetes-protected phenotype found in Nod2
-/-
NOD mice is mediated 
by gut microbiota and co-housing Nod2
-/-
NOD and Nod2
+/+
NOD mice can alter the 
composition of gut microbiota, leading to a change in diabetes phenotype.  However, our 
data show a reduction of SFB in the protected mice, thus do not support a protective role of 
SFB in diabetes development in these mice.  
Nod2-deficiency has been shown to reduce the level of antimicrobial peptides (AMPs) 
and thus alter the gut microbiota in other models [16, 18]. Therefore, we investigated 
whether AMPs contribute to the altered gut microbiota composition in Nod2
-/-
NOD and 
Nod2
+/+
NOD mice, both cohoused and non-cohoused.  As expected, non-cohoused 
Nod2
-/-
NOD mice had reduced levels of AMPs (particularly Reg3β) compared to 
non-cohoused Nod2
+/+
NOD mice (Supplemental Fig. 1B-D).  Further, cohousing 
significantly increased AMP levels, as others have previously reported [24].  This suggests 
that alterations in AMP expression were at least partly responsible for the altered 
microbiota.  
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3.3. Effect of Nod2 on macrophages (Mφ) and dendritic cells (DCs)   
We next examined the phenotype of the immune cells from cohoused and 
non-cohoused mice.  As antigen presenting cells (APCs), especially Mφ and DCs, are able 
to take up and present antigens from the gut lumen [25, 26], we hypothesized that APCs 
contributed to the modulation of T1DM susceptibility associated with Nod2.  However, the 
frequency and phenotype of CD11b
+
 Mφ or CD11c+ DCs in WT and Nod2-deficient NOD 
mice were comparable, regardless of the housing conditions (data not shown).  We then 
tested the function of Mφ and DCs using purified CD11b+ and CD11c+ populations from 
Nod2
+/+
NOD and Nod2
-/-
NOD mice.  There were no obvious differences in APC function, 
assessed by stimulation of diabetogenic CD4
+
 BDC2.5 T-cells or CD8
+
 NY8.3 T-cells in 
vitro between Nod2
-/-
NOD or Nod2
+/+
NOD mice (Supplementary Fig. 2A and B).  Finally, 
we tested the Mφ and DCs in vivo, in adoptive transfer experiments in immune-deficient 
hosts.  We transferred diabetogenic T-cells, from diabetic Nod2
+/+
NOD mice, to Nod2
-/-
 
and Nod2
+/+ 
NOD.scid mice and evaluated diabetes development in the recipients.  In line 
with our in vitro results, endogenous Mφ and DCs in Nod2-sufficient or deficient NOD.scid 
mice did not affect the incidence of diabetes in the recipients (Supplementary Fig 2C).  
These results suggest that the Mφ and DCs are not responsible for altered Nod2-mediated 
spontaneous diabetes susceptibility, unlike the streptozotocin-induced model [27].  
 
3.4. Effect of Nod2 on mucosal B-cells  
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We hypothesized that Nod2 may affect B-cell function, particularly IgA-producing 
B-cells.  Therefore, we investigated the proportion of IgA
+
 B-cells in the Peyer’s patches 
(PPs).  While there was a comparable proportion of IgA-producing B-cells in PPs of 
Nod2
-/-
NOD and Nod2
+/+
NOD mice when housed separately (Fig. 3A), co-housing led to a 
significant increase of IgA-producing B-cells in PPs of Nod2
-/-
NOD mice.  A similar trend 
was also seen in cohoused Nod2
+/+
NOD mice (Fig. 3A).  An increase in secreted IgA was 
also detected in the small intestine (Fig. 3B).  This suggests that the cohousing induced 
altered gut microbiota, which in turn promoted mucosal B-cell responses, whereas in the 
steady state of gut microbiota, IgA-producing mucosal B-cells were not affected by Nod2.  
PP-residing IgG2b-expressing B-cells were also influenced by cohousing, as non co-housed 
Nod2
-/-
NOD mice had lower levels of IgG2b-expressing B-cells compared to co-housed 
Nod2
-/-
NOD mice (Fig. 3C).  Further, IgG1-expressing B-cells were increased in CH WT 
Nod2
+/+
NOD mice when compared to CH Nod2
-/-
NOD mice within the PP (Fig. 3D).  
Together, these data suggest that the altered microbiota induced by cohousing affect the 
mucosal antibody responses.  
 
3.5. Effect of Nod2 on T-cells  
To investigate if Nod2 affects T-cell function, we examined cytokine expression of 
T-cells from spleen, PLN and PPs.  We found that, in the absence of Nod2, co-housing led 
to a significant increase of IFNγ-producing CD8+ T-cells in PPs of Nod2-/-NOD mice 
compared with non-cohoused Nod2
-/-
NOD or cohoused Nod2
+/+
 NOD mice (Fig. 4A).  
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Interestingly, a lower percentage of splenic IL-17A-producing CD4
+
 T-cells was seen in 
Nod2
-/-
NOD mice whereas co-housing significantly increased the percentage of 
IL-17A-producing CD4
+
 T-cells in PLN and PPs of Nod2
-/-
NOD mice compared with 
non-cohoused Nod2
-/-
NOD or Nod2
+/+
NOD mice (Fig. 4B).  SFB have been shown to 
induce IL17-expressing T cells [28].  Interestingly, the CD4
+
IL17a
+
 T cells showed a 
similar pattern to the level of SFB detected (Fig 2H), particularly splenic CD4
+
IL17a
+
 T 
cells (Fig. 4B).  The increased proportion of IL17-expressing CD4
+
 T cells in both the PLN 
and PP from cohoused Nod2
-/-
NOD mice that had increased diabetes suggests that other 
microbiota are capable of inducing IL17 in CD4 T cells.          
Next we investigated whether housing conditions affect Tregs.  We found 
proportional changes in CD4
+
CD25
+
FoxP3
+
 T-cells predominantly in the PLNs (Fig. 5A 
and B).  Interestingly, the Nod2
+/+
NOD mice housed separately, which have the highest 
incidence of diabetes, had the lowest proportion of Tregs.  Further, the Nod2
+/+
NOD 
co-housed with Nod2
-/-
NOD mice (which reduced diabetes onset) or the Nod2
-/-
NOD mice 
housed separately (which have the lowest incidence of diabetes), had the highest proportions 
of Tregs.  Our results suggested a role of the gut microbiota in inducing Tregs (Fig. 5A).  
To assess Treg function, we performed suppression assays using MLRs, in which T-cells 
from C57BL/6 mice (responders) were co-cultured with mitomycin-c treated NOD APCs 
(stimulators) in the presence of purified Treg cells (suppressors) from Nod2
+/+
NOD and 
Nod2
-/-
NOD mice (housed together or separately).  We found significant suppression of the 
proliferation of responder cells in the presence of Treg cells at 1:3 Treg:Tresponder ratio 
(Fig. 5C), although no suppression was observed at a 1:10 ratio (data not shown).  Thus, 
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housing status, which altered gut microbiota, affected both the number and function of the 
Treg cells.  Secreted cytokines in the supernatants of the Treg suppression assays revealed 
a significant increase in anti-inflammatory IL-10, associated with Nod2 deficiency (Fig. 
5D).  Similar results were seen in an autoantigen-specific Treg suppression assay (data not 
shown). 
 
3.6. Direct effect of gut microbiota on T-cell function 
To confirm if the housing-dependent change in gut microbiota was responsible for the 
different immune responses in the Nod2
-/-
NOD mice, we stimulated splenocytes from 
2-month old female Nod2
-/-
NOD and Nod2
+/+
NOD mice with heat-inactivated colonic 
bacteria of Nod2
-/-
NOD or Nod2
+/+
NOD mice.  Similar to the ICC staining shown (Fig. 4), 
there was a significant reduction of IFN-γ producing CD8
+
 T-cells from Nod2
-/-
NOD mice 
when compared to Nod2
+/+
NOD mice, in response to gut bacteria from either Nod2-deficient 
or sufficient mice (Fig. 6A).  However, gut bacteria from Nod2
+/+
NOD mice induced a 
greater IFN-γ production from CD8
+
 T-cells from Nod2
-/-
NOD or Nod2
+/+
NOD mice (Fig. 
6A), indicating that gut bacteria from Nod2
+/+
NOD mice are more inflammatory.  
Interestingly, the gut bacteria, regardless of the donor, appeared to suppress 
IL-17A-producing CD4
+
 T-cells (Fig. 6B) and we did not find direct effects of gut bacteria 
on TNF-α or IL-10-producing T-cells in vitro (data not shown).  
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Taken together, our results suggest Nod2
-/-
NOD mice had a distinct gut microbiota 
composition compared with Nod2
+/+
NOD mice, and that the variance in components of gut 
microbiota altered the immune cell function which modulates T1DM susceptibility.  
To further prove the concept, we colonized germ-free (GF) NOD mice with feces from 
4-5 week old Nod2
-/-
NOD or Nod2
+/+
NOD mice that were housed separately.  We studied 
the ex-GF mice 2-3 weeks after introduction of gut bacteria.  16S rRNA sequencing results 
showed a clear separation in the recipients depending on the donor microbiota they received 
(Fig. 7A).  Interestingly, we found increased cecal weight in the ex-GF mice given 
Nod2
-/-
NOD feces (Supplemental Fig. 3A) and the small intestine was also longer (data not 
shown), neither of which were observed in SPF Nod2
-/-
NOD mice (data not shown).  We 
also found reduced inflammatory cytokine-producing B cells, T cells in PLNs of ex-GF 
mice colonized with Nod2
-/-
NOD fecal bacteria (Fig. 7B).  In line with the reduction of 
inflammatory cytokine production by immune cells, these mice also had a higher frequency 
and absolute number of CD4
+
CD25
+
FoxP3
+
 Treg cells in the mesenteric lymph nodes 
(MLNs) and PPs compared to their counterparts colonized with Nod2
+/+
NOD fecal bacteria 
(Fig. 7C-E).   
There were no changes in phenotype and cytokine production in DCs or Mφ in the 
ex-GF mice (data not shown).  However, given the results of the changes in IgA
+
 B-cells in 
cohoused SPF Nod2
-/-
NOD mice and altered cytokine production in the ex-GF mice 
colonized with Nod2
-/-
NOD fecal bacteria (Fig. 3 and 7B), we tested islet-specific APC 
function of the B-cells in these conventionalized GF mice.  Supporting the immune tolerant 
status of these B-cells, B-cells from the ex-GF mice colonized with Nod2
-/-
NOD fecal 
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bacteria showed attenuated antigen presentation to both BDC2.5 CD4
+
 T-cells and NY8.3 
CD8
+
 T-cells compared to the B-cells from the ex-GF mice colonized with Nod2
+/+
NOD 
bacteria (Supplementary Fig. 3B-C).  Taken together, we provide evidence that Nod2 alters 
the composition of gut microbiota, which in turn modulate the adaptive immune system and 
influence diabetes susceptibility.  
 
4. Discussion: 
Our study sought to understand the role Nod2 plays in the development of spontaneous 
T1DM susceptibility. Our key finding was that Nod2-mediated T1DM susceptibility was 
dependent on the composition of the gut microbiota, which could be influenced by the 
housing of Nod2-deficient or sufficient NOD mice.  The Nod2-deficient NOD mice were 
protected from T1DM development, if they were housed only with Nod2-deficient NOD 
mice.  However, the disease protection was diminished if they were housed with 
Nod2-sufficient littermates.  Conversely, the higher incidence of the Nod2-sufficient NOD 
mice was reduced when these mice were housed with their Nod2-deficient NOD littermates, 
emphasizing the importance of gut bacteria in influencing diabetes incidence.  This was 
further confirmed by housing Nod2-deficient mice with Nod2-sufficient non-littermate mice.  
Although Nod2 deficiency led to a distinctive community of gut microbiota in NOD mice, 
its effect on diabetes was masked by the dominant community from Nod2-sufficient mice 
when cohoused.  Thus, one of the roles of the Nod2 gene in T1DM development was to 
alter the gut microbiota.  While macrophages and DCs were unaffected by Nod2 deficiency, 
the phenotype and functions of T- and B-cells were altered, some of which was likely to be 
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related to the gut microbiota composition.  This suggests that Nod2 activation is important 
for mediating changes in the gut microbiota, which affects the adaptive immune cells and 
subsequently diabetes development.  
We recently showed that NLRP3 alters T1DM development by limiting the recruitment 
and infiltration of autoreactive CD4
+
 T-cells into the pancreas [15].  Our current study 
provides evidence that NLR signaling is important for modulating diabetes susceptibility by 
alteration of the microbial composition, which in turn affects the phenotype and functions of 
immune cells.  Furthermore, this study demonstrates that the Nod2 gene effect on T1DM 
susceptibility is due to altering the composition of gut microbiota, and diabetes protection in 
Nod2-deficient mice is dependent on the gut microbial conditioning.  This was supported 
by the results from three sets of experiments: i) cohousing Nod2
-/-
NOD with Nod2
+/+
NOD 
mice, littermates or non-littermates, ii) investigating the role of Nod2 in non-cohoused 
Nod2
-/-
NOD mice, in which diabetes development was significantly reduced; iii) 
reconstitution of gut microbiota from Nod2
-/-
NOD or Nod2
+/+
NOD to germ-free NOD mice.   
The diabetes incidence differences in Nod2
-/-
NOD mice, when living with different 
housing partners, strongly supports the role of gut microbiota.  We found a distinct profile 
of the gut microbiota between Nod2
-/-
NOD and Nod2
+/+
NOD mice when they are housed 
separately, which correlated with diabetes development.  It is known that Nod2 is 
important for the expression of antimicrobial peptides and in controlling the expansion of 
intestinal bacteria [16, 18].  In line with those reports, we found Nod2-deficient NOD mice 
expressed reduced levels of antimicrobial peptides; however, upon cohousing with 
Nod2-sufficient NOD mice, the levels of AMPs were increased.  This suggests that the 
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secretion of antimicrobial peptides is gut microbiota-dependent but can be independent of 
Nod2, as others have reported [24].  Therefore, the alterations of gut microbiota 
composition in the Nod2
-/-
NOD mice, caused by cohousing with Nod2
+/+
NOD mice, induce 
a large increase in AMP synthesis to similar levels seen in the Nod2-sufficient mice, thereby, 
diminishing diabetes protection in Nod2-deficient mice. 
Interestingly, Nod2 deficiency had no effect on professional APCs, such as 
macrophages or DCs.  However, the APC function of B-cells was attenuated in the absence 
of Nod2 or in the presence of Nod2
-/-
NOD gut microbiota.  Nod2 deficiency also altered 
IgA-producing B-cells.  It is well documented that a large amount of IgA is secreted into 
the gut lumen to protect the host from microbial invasion [29-31].  In Nod2 deficiency, a 
mild reduction of secreted IgA in gut lumen was observed; however, cohousing with 
Nod2
+/+
NOD mice significantly promoted IgA production into the gut lumen.  This 
indicated that the gut microbiota tightly regulate the intestinal immune system in response to 
the newly-introduced gut bacteria by cohousing.  Cohousing of Nod2
-/-
NOD
 
mice with 
Nod2
+/+
NOD mice also affected pro-inflammatory cytokine-producing T cells and Treg 
cells in the lymphoid tissue outside the intestine including PLN.  This indicates that PLN 
have an intimate relationship with gut mucosal immunity.  Turley has reported that PLNs 
drain antigens from both pancreas and intestine [32].  In line with this observation, we 
recently found a commensal microbial antigen that can be recognized by diabetogenic T 
cells, which in turn attack islet beta cells [33].  Similar results were also observed in an 
autoimmune uveitis model [34].  It is conceivable that Nod2
-/-
NOD
 
mice harbor less 
diabetogenic gut microbiota, and thereby have a lower frequency of proinflammatory 
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cytokine-producing T-cells but a higher frequency of Treg cells in PLNs.  However, more 
immunostimulatory gut microbiota were present in Nod2
-/-
NOD mice after cohousing with 
WT mice, which led to a higher frequency of proinflammatory cytokine-producing T-cells 
and increased disease onset.  The proof of concept using GF mice confirmed our 
hypothesis.  
Costa reported recently that Nod2 is important in streptozotocin-induced diabetes in 
C57BL/6 mice [27].  Although both our study and theirs demonstrated increased Tregs in 
response to Nod2
-/-
 microbiota, the cause of the Treg increase in the two model systems was 
different.  In our spontaneous T1DM model, gut microbiota affected by housing status, 
regulated the change of Tregs; however, the anti-inflammatory cytokine IL-10 production 
was regulated by Nod2 gene expression (or lack of expression) but independent of housing 
conditions.  While Costa and colleagues showed that CD11b
+
CD11c
+
 cells were important 
for mediating suppression and diabetes protection in their streptozotocin-induced disease 
model, we did not observe any changes in both phenotype and function of DCs or 
macrophages in vitro and in vivo.  The changes we observed were in the B and T-cells in 
our spontaneous diabetes model.  The discrepancy between the two studies was most likely 
due to the two very different model systems, streptozotocin-induced diabetes and 
spontaneous T1DM.  More importantly, the two studies also used two very different mouse 
strains with different genetic backgrounds, C57BL/6 vs NOD.   
Our study also raises a very important issue of housing conditions in interpretation of 
the disease phenotype in a genetically-targeted mouse strain.  We propose that the 
phenotype should be tested in two housing conditions – cohousing with gene-sufficient 
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littermates and housing separately from gene-sufficient mice.  If the disease phenotype is 
affected by the housing conditions when housed separately, as in our study, but not when 
cohoused, it suggests that the change in the gut microbiota is an integral part of the effect 
exerted by the specific gene.  
Although the mouse Nod2 protein shares high homology with human Nod2 protein 
[35], it is not known if Nod2 has genetic associations with human T1D.  However, a recent 
study suggests a high prevalence of inflammatory bowel disease (IBD) in patients with T1D 
[36].  It is not clear whether the patients developed IBD first or T1D first; however, Nod2 
is a major susceptibility gene for IBD [19, 20] and Nod2 plays an important role in 
mediating microbial signaling responses.  It is possible that activation of Nod2 pathway 
may be context-dependent in individuals with T1D, i.e., dependent on microbial exposure, 
as we found in NOD mice.   
In conclusion, our data suggest that Nod2 plays a role in T1DM development.  
Unlike inflammatory bowel disease, where the Nod2 gene plays a dominant role in the 
disease development, in T1DM, the role of the Nod2 gene contributes to alteration of the gut 
microbiota, but this effect can be over-ridden by altering the housing conditions.  Thus, 
Nod2 acts as a recessive modulator in T1DM susceptibility.  Finally, as human T1D 
incidence is increasing, this adds further weight to the increased importance of 
environmental factors in human studies.   
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Figure legends 
Fig. 1 - Diabetes development in Nod2
-/-
NOD mice is dependent on housing status. 
(A), Diabetes development was observed in female Nod2
-/-
NOD and Nod2
+/+
NOD mice that 
were reared together (CH, co-housed) or (B) separated by genotype (NCH, non-cohoused).  
(C), Diabetes development was observed in female Nod2
-/-
NOD and Nod2
+/+
NOD mice that 
were born from different mothers and either the strains were cohoused post-weaning (CH) 
or housed with littermates of their own genotype (NCH).  Mice were screened weekly for 
glycosuria and confirmed by blood glucose ＞ 250 mg/dL (>13.9 mmol/L).  The 
observation was terminated when the mice were 30 weeks old.  Statistical analysis was 
performed by Log-rank test. 
 
Fig. 2 - The composition of gut microbiota in Nod2
-/-
NOD mice is dependent on housing 
status  
Bacterial DNA was extracted from fecal pellets from non-cohoused and cohoused 12-week 
old Nod2
-/-
NOD and Nod2
+/+
NOD female mice (n=5-6/group, randomly selected from the 
mice in Fig. 1C) and used for pyrosequencing.  Principal component analysis (unweighted) 
of beta diversity of the gut microbiota in Nod2
+/+
NOD and Nod2
-/-
NOD female mice is 
shown for non-cohoused (Fig. 2A) and cohoused (Fig. 2B) mice.  The composition of gut 
microbiota was compared at genus level between Nod2
-/-
NOD and Nod2
+/+
NOD mice (n=6 
each) which were cohoused (CH) or non-cohoused (NCH) (Fig. 2C-G).  The abundance of 
SFB in the gut microbiota was assessed by qPCR with SFB specific primers (Fig. 2H).  
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The level of SFB expression was calculated by the delta-delta threshold cycle method after 
normalization with bacterial 16S rRNA.  Each sample was plated in triplicate and the 
experiments were repeated twice.  Student’s t test was used for statistical analysis (*P<0.05; 
**P<0.001). Error bars represent SEM. 
 
Fig. 3 - Cohousing affects IgA, IgG2b and IgG1 secreting B-cells in the PP and gut 
lumen 
(A), IgA secreting B-cells (CD19
+
IgA
+
 B-cells) in the Peyer’s patches were investigated in 
12-week old female Nod2
-/-
NOD and Nod2
+/+
NOD mice using flow cytometry.  Left: A set 
of representative FACS plots.  Right: The graphical summary of the IgA-secreting B-cells 
in the 4 groups (n=8, pooled from two independent experiments).  (B), IgA concentration 
in the small intestine of Nod2
-/-
NOD and Nod2
+/+
NOD mice cohoused (CH) or 
non-cohoused (NCH) was measured by ELISA.  Data for (B) are from 3 individual 
experiments (n=7-8).  (C) and (D) IgG2b-secreting B-cells and IgG1-secreting B-cells in 
the Peyer’s patches were investigated in 12-week old female Nod2
-/-
NOD and Nod2
+/+
NOD 
mice using flow cytometry (n=4).  Student’s t test was used for statistical analysis. 
*P<0.05, **P<0.01.  Error bars represent SEM. 
    
Fig. 4 - Cytokine-producing CD4
+
 and CD8
+
 T-cells are altered by the absence of Nod2 
and the cohousing conditions   
Intracellular staining was conducted on T cells from the spleen, pancreatic lymph nodes 
(PLN) and Peyer’s patches (PP) from 12-week old female Nod2
-/-
NOD (KO) and 
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Nod2
+/+
NOD mice in both cohoused (CH) and non-cohoused (NCH) conditions.  (A), The 
percentages of IFNγ-producing CD8+ T-cells and (B), IL-17a-producing CD4+ T-cells.  
The data represent at least 3 independent experiments (n=3-4/group/experiment).  
Student’s t test was used for statistical analysis. *P<0.05; **P<0.001; *** P<0.0001. Error 
bars represent SEM. 
 
Fig. 5 –Treg proportion and function is affected by cohousing 
Intracellular staining was conducted on T-cells from the spleen, pancreatic lymph nodes 
(PLN), mesenteric lymph nodes (MLN) and Peyer’s patches (PP) from 12-week old female 
Nod2
-/-
 NOD (KO) and Nod2
+/+
NOD mice in both cohoused (CH) and non-cohoused (NCH) 
conditions.  (A), Representative Treg FACS plots shown for each group (gated on Live 
single B220-TCRbeta+CD8a-CD4+CD25+FoxP3+ cells).  (B), Compiled data from A, 
(n=6-8).  Pancreatic lymph node CD4+CD25+ Tregs were isolated using magnetic beads 
from 12-week old Nod2
+/+
NOD and Nod2
-/-
NOD KO mice in both cohoused and 
non-cohoused conditions and mitomycin-c-treated (20mins, 37°C).  NOD Splenic T cells 
were depleted using complement to enrich APCs, which were then mitomycin-c treated 
(100,000/well).  Isolated splenic T-cells from 12 week-old C57BL/6 mice were isolated 
and co-cultured with Tregs at a ratio of 1:3 (Treg:Tresponder) for 5 days, prior to 
supernatant collection and thymidine addition for the last 18 hours.  (C), Proliferation 
suppression was calculated by (100-proliferation)/control x 100. Control was defined as the 
proliferation when no Tregs were added.  (D), Supernatants were tested for the 
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concentration of IL-10 by ELISA.  Data shown are pooled from two independent 
experiments. Statistical analysis was performed using Student t test, *P<0.05; **P<0.0001. 
 
Fig. 6 - The direct effect of gut microbiota on immune cells 
Gut bacteria from the large intestine of Nod2
-/-
NOD or Nod2
-+/+
NOD mice were harvested 
and used to stimulate splenocytes (5×10
6
/ml)
 
from Nod2
-/-
NOD or Nod2
-+/+
NOD mice with 
or without heat-inactivated gut bacteria (10
8
 cfu) for 14 hours.  The expression of IFN-γ in 
CD8
+
 T-cells (A) and IL-17A (B) in CD4
+
 T-cells was assessed by intracellular cytokine 
staining.  Representative FACS plots are shown on the top.  The results are pooled from 
three independent experiments. Student’s t test was used for statistical analysis. * P<0.05; 
**, P<0.001; ***,
 
P<0.0001. * Data comparison was between cells incubated with no 
bacteria (control) and either Nod2
-/-
NOD or Nod2
-+/+
NOD derived bacteria (A and B) or 
between Nod2
-/-
NOD or Nod2
-+/+
NOD derived bacteria stimulation (A).	
	
Fig. 7 – Colonization of GF NOD with bacteria alters immune cell cytokine secretion 
and function 
GF NOD mice were gavaged once with 2x10
8
 CFU fecal bacteria from 4-5 week old KO 
Nod2
-/-
NOD or Nod2
-+/+
NOD mice.  Bacterial DNA was extracted from fecal pellets from 
WT or KO gavaged ex-GF NOD mice (n=7/group) and the original bacteria donors. 
Pyrosequencing was conducted using the Ion Torrent PGM sequencing system.  The 
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sequencing data were analyzed with QIIME software package and UPARSE pipeline to pick 
operational taxonomic units (OTUs).  Taxonomy assignment was performed at phylum 
level using representative sequences of each OTU.  Principal component analysis 
(unweighted) of beta diversity of the gut microbiota from WT gavaged and KO gavaged 
mice is shown (A). 2-3 weeks later mice were sacrificed for immunophenotyping. 
Intracellular staining was conducted on B-cells (gated on live single 
TCRbeta-CD11b
-
CD11c
-
B220
+
) and T-cells (gated on live single TCRbeta
+
B220
-
 cells then 
CD4 or CD8) from the pancreatic lymph nodes (B). FoxP3 staining was conducted 
following the instructions from the eBioscience staining kit for cells from spleen, pancreatic 
lymph nodes (PLN), mesenteric lymph nodes (MLN) and Peyer’s patches (PP). Cells were 
gated on live single B220
-
TCRbeta
+
CD8a
-
CD4
+
CD25
+
FoxP3
+
 cells (C). Absolute numbers 
were calculated for MLN (D) and PP (E) Treg cells. All data shown are pooled from two 
independent experiments (n=3-4/experiment). Statistical analysis was performed using 
Student’s t test, *P<0.05 or **P<0.0001. Lines represent the mean and the standard 
deviation. 
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Supplemental Figure Legends 
Supplemental Fig. 1 – Nod2 and cohousing alter the gut microbiota and antimicrobial 
peptide expression 
 (A) Bacterial DNA was extracted from fecal pellets from Nod2
+/+
NOD homozygous and 
Nod2
-/-
NOD homozygous breeder litters at 3 weeks of age (prior to changes in housing) and 
8-9-weeks of age from cohoused (CH) and non-cohoused (NCH) Nod2
-/-
NOD and 
Nod2
+/+
NOD female mice (n=4-8/group, selected from the mice in Fig. 1C) and used for 
pyrosequencing.  Principal component analysis (unweighted) of beta diversity of the gut 
microbiota in cohoused and non-cohoused Nod2
+/+
NOD and Nod2
-/-
NOD female mice is 
shown (A). (B-D) Distal small intestinal RNA from 13-14-week old Nod2
-/-
NOD and 
Nod2
+/+
NOD female mice (cohoused and non-cohoused) was used to generate cDNA. 
QPCR was then conducted for the antimicrobial peptides (Reg3γ, Reg3β and RelmB).  
Samples were compared to GAPDH and fold change was generated from ΔΔCT values.  
Statistical analysis was performed using Student t test; *P<0.05 or  **P<0.01. 
Supplemental Fig. 2 - Nod2 deficiency does not alter the function of DC or 
macrophages  
Antigen presenting function of Nod2
-/-
NOD mice was tested in vitro (A, B) and in vivo (C).    
Splenic macrophages (Mφ) (CD11b+) and DC (CD11c+) cells, from Nod2-/-NOD and 
Nod2
+/+
NOD mice, were purified with purification kits (Stem Cell Technology) and co-
cultured (10
4
) with purified CD4
+
 T-cells (10
5
) from BDC2.5 TCR transgenic NOD mice (A) 
or CD8
+
 T-cells (10
5
) from NY8.3 TCR transgenic NOD mice (B) in the presence or 
	 2	
absence of BDC2.5 mimotope peptide or IGRP206-214 peptide at various concentrations for 
72 hours before adding thymidine (
3
H).  The cells were harvested 18 hours later; thymidine 
incorporation was measured by beta-counter.  Data are shown as counts per minute (cpm) 
after subtraction of the background (~200 – 1,000 cpm).   
To test the antigen presenting function, in vivo, splenic T-cells from Nod2
-/-
NOD mice and 
Nod2
+/+
NOD mice were transferred (10
7
/mouse) into immunodeficient NOD.scid 
(Nod2
+/+
NOD.scid) or Nod2
-/-
NOD.scid recipients.  Mice were screened daily post-transfer 
for glycosuria and diabetes development confirmed with a blood glucose level >250mg/dl 
(C). 
 
Supplemental Fig. 3 – Reconventionalized GF NOD mice exhibit increased cecal 
weight and B cells with reduced antigen presenting capabilities  
GF NOD mice were gavaged once with 2x10
8
 CFU fecal bacteria from 4-5 week old 
Nod2
+/+
NOD or Nod2
-/-
NOD mice.  2-3 weeks post gavage, mice were sacrificed and cecal 
weights (A) were measured.  Splenic B-cells were isolated from the mice using magnetic 
beads and subsequently mitomycin-c treated.  BDC2.5 CD4
+
 (B) and NY8.3 CD8
+
 (C) T-
cells were isolated from BDC2.5 and NY8.3 transgenic mice, respectively, and co-cultured 
at a 1:1 ratio with B-cells and mimotope/peptide.  Cells were cultured for 48 hours and 
thymidine was added to assess cell proliferation for the last 18 hours.  Data are shown after 
subtraction of background (cpm ~350-800) and are pooled from two independent 
	 3	
experiments (n=3-4/experiment).  Statistical analysis was performed using Student t test; 
**P<0.0001 (B) or two way ANOVA; **P<0.0001 (C and D). 
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Supplemental Information 
Supplementary Table 1 – Summary of Mouse Breeding and observation cohorts 
					Group	 	Breeding	 Housing	Partners	 Housing	Partners	 							Gut		 Incidence	of	 	 				Related		
	 	 	 						(from	birth)		 				(post-weaning)	 Microbiota	 				Diabetes	 	 				Figures	
										1	 											Nod2
+/-
 x Nod2
+/-   
Nod2
-/-
 and Nod2
+/+  
Nod2
-/-
 and Nod2
+/+        
Shared       Similar   Figure 1A (CH) 
         2           Nod2
+/-
 x Nod2
+/-   
Nod2
-/-
 and Nod2
+/+  
Housed by genotype
      
Different  Nod2
-/-
 have  Figure 1B (NCH) 
                       reduced diabetes  
                          vs Nod2
+/+
   
         3           Nod2
-/-
 x Nod2
-/-    
         Nod2
-/-
 
   
          Nod2
-/-        
  Different       NCH Nod2
-/-
 have      Figure 1C 
                       reduced diabetes    (CH and NCH) 
                        vs NCH Nod2
+/+
  
         4           Nod2
+/+
 x Nod2
+/+ 
          Nod2
+/+
 
   
          Nod2
+/+        
  Different       NCH Nod2
-/-
 have      Figure 1C 
                       reduced diabetes    (CH and NCH) 
                        vs NCH Nod2
+/+
 	
CH	=	Cohoused	-	both	genotypes	in	each	cage	(Nod2+/+	and	Nod2-/-)	
NCH	=	Non-cohoused	-	One	genotype	in	each	cage	(Nod2+/+	or	Nod2-/-)		
